Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT06365398

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06365398
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06365398. Randomized; triple masking; primary purpose treatment. Start 2018-01-01 (actual); primary completion 2021-06-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy
Acronym
SELECT
Condition
Cerebral Angiography
Condition
Heparinization
Intervention (Drug)
Heparin
Intervention (Drug)
Heparin Sodium Injection
Intervention (Other)
No heparinization
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct06365398
Content hash
2ea75a131b562d1a3798618116fe358dc4504a7c4c55a9f7443788d28bc9840d